Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes
- 1 October 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 189 (4) , 980-985
- https://doi.org/10.1067/s0002-9378(03)00721-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk populationUltrasound in Obstetrics & Gynecology, 2001
- Efficacy of screening for fetal down syndrome in the United States from 1974 to 1997Obstetrics & Gynecology, 2000
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesisThe Lancet, 1998
- Antenatal Screening for Down's SyndromeJournal of Medical Screening, 1997
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- The Safety and Efficacy of Chorionic Villus Sampling for Early Prenatal Diagnosis of Cytogenetic AbnormalitiesNew England Journal of Medicine, 1989
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENPublished by Elsevier ,1986
- Down's SyndromeJAMA, 1981
- Midtrimester Amniocentesis for Prenatal DiagnosisJAMA, 1976